PharmGKB summary: lamotrigine pathway, pharmacokinetics and pharmacodynamics is a research paper published in Pharmacogenetics and Genomics (2020). On theSindex it has a DataRank of 1.6. It has been cited 52 times, with 47 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.596
From this paper's citation signal
Citation Network Contribution
0.999
From 33 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 47 citers.
National Institutes of Health
Grant: 5R24GM061374-13
PharmGKB: From Association to Mechanism
National Institutes of Health
Grant: 5P50NS016308-10
MINNESOTA COMPREHENSIVE EPILEPSY PROGRAM
Fields of Study
Keywords
Additional file 1 of Identifying the natural products in the treatment of atherosclerosis by increasing HDL-C level based on bioinformatics analysis, molecular docking, and in vitro experiment
Additional file 1 of Identifying the natural products in the treatment of atherosclerosis by increasing HDL-C level based on bioinformatics analysis, molecular docking, and in vitro experiment
Additional file 2 of Identifying the natural products in the treatment of atherosclerosis by increasing HDL-C level based on bioinformatics analysis, molecular docking, and in vitro experiment
Additional file 2 of Identifying the natural products in the treatment of atherosclerosis by increasing HDL-C level based on bioinformatics analysis, molecular docking, and in vitro experiment